H1N1 Vaccines Market Size, Share, Analysis, Trends, Growth, 2032

H1N1 Vaccines Market

H1N1 Vaccines Market - By Route Of Administration (Intradermal Vaccines, Intranasal Vaccines, and Intramuscular Vaccines), And By Region - Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024 - 2032-

Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-2976 Published Date: Oct-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 3.79 Billion USD 5.90 Billion 4.5% 2023

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. H1N1 Vaccines Market, 2015–2025 (USD Billion)
    • 2.2. H1N1 Vaccines Market: Snapshot
  • Chapter 3. Global H1N1 Vaccines Market– Industry Analysis
    • 3.1. H1N1 Vaccines Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. With large number of vaccine producers emerging in countries such as India, China, and Thailand as well as countries of South America, the H1N1 vaccines industry is anticipated to witness accelerated growth in the coming decade.
      • 3.2.2. Growing awareness among the patients about preventing swine flu and technulogical breakthroughs in the healthcare sector is projected to pave a way for the market growth over the upcoming years.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Route of Administration
  • Chapter 4. Global H1N1 Vaccines Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global H1N1 Vaccines Market: company market share, 2017
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global H1N1 Vaccines Market– Route of Administration Analysis
    • 5.1. Global H1N1 Vaccines Market overview: By Route of Administration
      • 5.1.1. Global H1N1 Vaccines Market share, By Route of Administration, 2018 and 2025
    • 5.2. Intradermal Vaccines
      • 5.2.1. Global H1N1 Vaccines Market By Intradermal Vaccines, 2015–2025 (USD Billion)
    • 5.3. Intranasal Vaccines
      • 5.3.1. Global H1N1 Vaccines Market By Intranasal Vaccines, 2015–2025 (USD Billion)
    • 5.4. Intramuscular Vaccines
      • 5.4.1. Global H1N1 Vaccines Market By Intramuscular Vaccines, 2015–2025 (USD Billion)
  • Chapter 6. Company Profiles
    • 6.1. GlaxoSmithKline
      • 6.1.1. Overview
      • 6.1.2. Financials
      • 6.1.3. Product Portfolio
      • 6.1.4. Business Strategy
      • 6.1.5. Recent Developments
    • 6.2. Medimmune
      • 6.2.1. Overview
      • 6.2.2. Financials
      • 6.2.3. Product Portfolio
      • 6.2.4. Business Strategy
      • 6.2.5. Recent Developments
    • 6.3. Novartis
      • 6.3.1. Overview
      • 6.3.2. Financials
      • 6.3.3. Product Portfolio
      • 6.3.4. Business Strategy
      • 6.3.5. Recent Developments
    • 6.4. AstraZeneca plc
      • 6.4.1. Overview
      • 6.4.2. Financials
      • 6.4.3. Product Portfolio
      • 6.4.4. Business Strategy
      • 6.4.5. Recent Developments
    • 6.5. Sinovac Biotech
      • 6.5.1. Overview
      • 6.5.2. Financials
      • 6.5.3. Product Portfolio
      • 6.5.4. Business Strategy
      • 6.5.5. Recent Development
    • 6.6. Sanofi AG
      • 6.6.1. Overview
      • 6.6.2. Financials
      • 6.6.3. Product Portfolio
      • 6.6.4. Business Strategy
      • 6.6.5. Recent Development
    • 6.7. Commonwealth Serum Laboratories
      • 6.7.1. Overview
      • 6.7.2. Financials
      • 6.7.3. Product Portfolio
      • 6.7.4. Business Strategy
      • 6.7.5. Recent Development
    • 6.8. Baxter
      • 6.8.1. Overview
      • 6.8.2. Financials
      • 6.8.3. Product Portfolio
      • 6.8.4. Business Strategy
      • 6.8.5. Recent Development
    • 6.9. Zydus Cadila
      • 6.9.1. Overview
      • 6.9.2. Financials
      • 6.9.3. Product Portfolio
      • 6.9.4. Business Strategy
      • 6.9.5. Recent Development

Table Of Figures

List of Figures

1. Market research process
2. Market research methodology
3. Global H1N1 Vaccines Market, 2015–2025 (USD Billion)
4. Porter’s Five Forces Analysis
5. Global H1N1 Vaccines Market attractiveness, By Route of Administration 
6.  Global H1N1 Vaccines Market Share by Route of Administration ,2018 and 2025 (USD Billion)
7. Global H1N1 Vaccines Market by Intradermal Vaccines ,2015–2025 (USD Billion)
8. Global H1N1 Vaccines Market by Intranasal Vaccines ,2015–2025 (USD Billion)
9. Global H1N1 Vaccines Market by Intramuscular Vaccines,2015–2025 (USD Billion)
10. Global H1N1 Vaccines Market share, by Region, 2018 and 2025
11. North America H1N1 Vaccines Market, 2015–2025 (USD Billion)
12. Europe H1N1 Vaccines Market, 2015–2025 (USD Billion)
13. Asia Pacific H1N1 Vaccines Market, 2015–2025 (USD Billion)
14. Latin America H1N1 Vaccines Market, 2015–2025 (USD Billion)
15. The Middle East and Africa H1N1 Vaccines Market, 2015–2025 (USD Billion)
 


Table Of Tables

List of Tables

1. Global H1N1 Vaccines Market: snapshot
2. Drivers of the H1N1 Vaccines Market: impact analysis
3. North America H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)
4. The U.S. H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)
5. Rest of North America H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)
6. Europe H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)
7. UK H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)
8. France H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)
9. Germany H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)
10. Rest of Europe H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)
11. Asia Pacific H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)
12. China H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)
13. Japan H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)
14. India H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)
15. Rest of Asia Pacific H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)
16. Latin America H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)
17. Brazil H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)
18. Rest of Latin America H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)
19. The Middle East and Africa H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)
20. Saudi Arabia H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)
21. South Africa H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)
22. Rest of the Middle East & Africa H1N1 Vaccines Market revenue, By Route of Administration , 2015–2025 (USD Billion)

 
 

Methodology

FrequentlyAsked Questions

Rise in the occurrence of H1N1 infection and reduction in the immunity of individuals along with fear of new H1N1 virus strain has enhanced the H1N1 vaccines market demand in the recent years. Apparently, rise in respiratory ailments with growing age and surge in immuno deficient ailments will prop up the growth of H1N1 vaccines market over the years ahead.

According to Zion market research report, the global H1N1 Vaccines Market, estimating its value at USD 3.79 Billion in 2023, with projections indicating that it will reach USD 5.90 Billion by 2032. The market is expected to expand at a compound annual growth rate (CAGR) of 4.5% over the forecast period 2024-2032. 

North America is likely to make noteworthy contributions towards overall market revenue during forecast period. The regional market growth over 2024 – 2032 can be credited to National Immunization Program started by the U.S. for inoculating people with H1N1 vaccines.

 

The key players profiled in the report include Baxter, Commonwealth Serum Laboratories, GlaxoSmithKline, Sanofi AG., Medimmune, AstraZeneca plc, Sinovac Biotech, Novartis, and Zydus Cadila.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed